Closing delivery gaps in the treatment of tuberculosis infection: Lessons from implementation research in Peru
Abstract
<jats:sec id="sec001">
<jats:title>Background</jats:title>
<jats:p>Targeted testing and treatment of TB infection to prevent disease is a pillar
of TB elimination. Despite recent global commitments to greatly expand access to preventive
treatment for TB infection, there remains a lack of research on how best to expand
preventive treatment programs in settings with high TB burdens.</jats:p>
</jats:sec>
<jats:sec id="sec002">
<jats:title>Methods</jats:title>
<jats:p>We conducted implementation research in Lima, Peru, around a multifaceted
intervention to deliver TB preventive treatment to close contacts of all ages, health
care workers, and people in congregate settings. Key interventions included use of
the interferon gamma release assay (IGRA), specialist support for generalist physicians
at primary-level health facilities, and treatment support by community health workers.
We applied a convergent mixed methods approach to evaluate feasibility and acceptability
based on a care cascade framework.</jats:p>
</jats:sec>
<jats:sec id="sec003">
<jats:title>Findings</jats:title>
<jats:p>During April 2019-January 2020, we enrolled 1,002 household contacts, 148
non-household contacts, 107 residents and staff of congregate settings, and 357 health
care workers. Cumulative completion of the TB preventive care cascade was 34% for
contacts <5 years old, 28% for contacts 5–19 years old, 18% for contacts ≥20 years
old, 0% for people in congregate settings, and 4% of health care workers. IGRA testing
was acceptable to adults exposed to TB. Preventive treatment was acceptable to contacts,
but less acceptable to physicians, who frequently had doubts about prescribing preventive
treatment for adults. Community-based treatment support was both acceptable and feasible,
and periodic home-visits or calls were identified as facilitators of adherence.</jats:p>
</jats:sec>
<jats:sec id="sec004">
<jats:title>Conclusions</jats:title>
<jats:p>We attempted to close the gap in TB preventive treatment in Peru by expanding
preventive services to adult contacts and other risk groups. While suboptimal, care
cascade completion for adult contacts was consistent with what has been observed in
high-income settings. The major losses in the care cascade occurred in completing
evaluations and having doctors prescribe preventive treatment.</jats:p>
</jats:sec>
Type
Journal articlePermalink
https://hdl.handle.net/10161/22391Published Version (Please cite this version)
10.1371/journal.pone.0247411Publication Info
Yuen, Courtney M; Millones, Ana Karina; Puma, Daniela; Jimenez, Judith; Galea, Jerome
T; Calderon, Roger; ... Keshavjee, Salmaan (n.d.). Closing delivery gaps in the treatment of tuberculosis infection: Lessons from implementation
research in Peru. PLOS ONE, 16(2). pp. e0247411-e0247411. 10.1371/journal.pone.0247411. Retrieved from https://hdl.handle.net/10161/22391.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
Tom Nicholson
Associate In Research
Tom Nicholson holds an appointment as Associate in Research at DCID, stemming from
a research partnership between DCID and Harvard Medical School’s Department of Global
Health and Social Medicine, with a focus on policy innovation in the global response
to drug-resistant tuberculosis. In this capacity he has co-founded Advance Access
and Delivery (AA&D), a global NGO focused on health care delivery in challenging settings,
which is aligned with Partners In Health (PIH), Harvard Medi

Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info